Authors/Disclosures
|
Alexandra J. Sinclair, MD
|
Dr. Sinclair has received personal compensation for serving as an employee of Invex Therapeutics. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Sinclair has stock in Invex Therapeutics (unclear what the company is developing but no longer working in the field of Idiopathic Intracranial Hypertension). The institution of Dr. Sinclair has received research support from DOD. The institution of Dr. Sinclair has received research support from MOD. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Asimina Athanasouli
|
Asimina Athanasouli has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Mark Lawden, MD
(Leicester General Hospital)
|
No disclosure on file |
|
Carl E. Clarke
(City Hospital NHS Trust)
|
No disclosure on file |
|
Alain Creange
(Hopital Henri Mondor)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |